Conversely, in plasma samples collected at 12, 24, and 48 h after symptoms onset in 39 patients with ischemic stroke, while MMP-9 concentrations were greater in stroke patients than the reference interval for healthy controls, no significant changes were reported over time (95). This evidence concerns the gene MMP9 and stroke disorder.